Opticlik insulin pen. OptiClik, OptiPen and OptiSet Insulin Pens Discontinued: What You Need to Know
Why were OptiClik, OptiPen and OptiSet insulin pens discontinued. What are the alternative insulin pen options now available. How does this change affect patients using the discontinued pens. What are the key features of the new SoloSTAR and ClikSTAR insulin pens.
The Discontinuation of OptiClik, OptiPen, and OptiSet Insulin Pens
In a significant move within the diabetes care industry, Sanofi-aventis has announced the discontinuation of several insulin pen devices. This decision comes in response to guidance published by the National Patient Safety Agency aimed at reducing insulin-related errors. The discontinued devices include:
- OptiClik (reusable)
- OptiPen Pro 1 (reusable)
- OptiSet (pre-filled disposable)
- Autopen 24 (reusable, distribution ceased by Sanofi-aventis)
This change marks a pivotal moment in diabetes management, streamlining the range of insulin delivery devices available to patients and healthcare professionals.
Introducing SoloSTAR and ClikSTAR: The New Standard in Insulin Pens
With the discontinuation of the older models, Sanofi-aventis is focusing on two primary insulin pen devices:
- SoloSTAR: A pre-filled disposable pen
- ClikSTAR: A reusable pen
These devices represent the latest in insulin delivery technology, designed to improve user experience and reduce the risk of medication errors. Both SoloSTAR and ClikSTAR offer enhanced features that cater to the needs of modern diabetes management.
Key Features of SoloSTAR and ClikSTAR Pens
- Dose selection range: 1-80 units of insulin per dose
- Precise dosing: Increments of 1 unit
- Compatibility: Works with existing insulin preparations
- Needle compatibility: Compatible with needles used for older devices
Impact on Patients: Transitioning to New Insulin Pen Devices
For patients currently using one of the discontinued pens, the transition to SoloSTAR or ClikSTAR should be relatively seamless. Here’s what patients need to know:
- No change in insulin: The same insulin preparations will be available for the new pen devices
- Needle compatibility: Existing needles can be used with the new pens
- Dosing consistency: Both new pens offer the same dosing range and precision
Healthcare providers should guide patients through this transition, ensuring they understand how to use the new devices effectively and safely.
Understanding the Benefits of SoloSTAR and ClikSTAR Insulin Pens
The shift to SoloSTAR and ClikSTAR pens brings several advantages for patients and healthcare professionals alike:
Improved Safety Features
How do the new pens enhance safety in insulin administration? The SoloSTAR and ClikSTAR pens incorporate design elements that help reduce the risk of dosing errors. These include clear dose displays, audible clicks for each unit dialed, and mechanisms to prevent accidental dose changes.
User-Friendly Design
What makes these pens more user-friendly? Both SoloSTAR and ClikSTAR feature ergonomic designs that make them easier to handle, especially for patients with dexterity issues. The large dose window and clear numbering improve visibility, reducing the chance of misreading doses.
Flexibility in Dosing
How flexible are the dosing options with the new pens? With a range of 1-80 units per dose in 1-unit increments, these pens offer precise control over insulin delivery. This flexibility allows for fine-tuning of insulin regimens to meet individual patient needs.
The Role of Healthcare Providers in the Transition
Healthcare providers play a crucial role in ensuring a smooth transition for patients moving to the new insulin pen devices. Here are key responsibilities for healthcare professionals:
- Patient education on new device usage
- Monitoring and adjusting insulin regimens as needed
- Addressing patient concerns and questions about the transition
- Ensuring proper disposal of old devices and unused insulin cartridges
By taking a proactive approach, healthcare providers can help minimize disruption to patients’ diabetes management routines and ensure continued adherence to treatment plans.
Long-Term Implications for Diabetes Management
The consolidation of insulin pen options to SoloSTAR and ClikSTAR has broader implications for diabetes care:
Standardization of Care
How does this change contribute to standardizing diabetes care? By reducing the variety of insulin delivery devices, there’s potential for more consistent training, reduced confusion among patients and healthcare providers, and potentially fewer medication errors.
Future Innovations
What does this mean for future developments in insulin delivery? Focusing on two primary devices may allow Sanofi-aventis to concentrate its research and development efforts, potentially leading to further innovations in insulin pen technology.
Cost Implications
How might this affect the cost of diabetes care? While the immediate impact on costs may vary, streamlining the product line could potentially lead to economies of scale in production, which might translate to cost benefits for healthcare systems and patients in the long run.
Comparing SoloSTAR and ClikSTAR: Choosing the Right Pen
While both SoloSTAR and ClikSTAR offer similar core functionalities, there are differences that may make one more suitable than the other for certain patients:
SoloSTAR: Pre-filled Disposable Pen
- Convenience: No need to load insulin cartridges
- Reduced risk of contamination: Each pen is used for a single insulin type
- Ideal for: Patients who prefer simplicity and minimal handling
ClikSTAR: Reusable Pen
- Cost-effective: Can be used multiple times with replaceable insulin cartridges
- Environmentally friendly: Generates less plastic waste over time
- Suitable for: Patients comfortable with loading cartridges and maintaining their device
Healthcare providers should discuss these options with patients to determine which pen best suits their lifestyle, preferences, and medical needs.
Addressing Common Concerns About the Transition
As with any change in medical devices, patients may have concerns about switching to SoloSTAR or ClikSTAR pens. Here are some common questions and their answers:
Will my insulin dose change?
No, the insulin dose remains the same. The new pens deliver the same insulin preparations as the discontinued models.
Do I need to learn a new injection technique?
While the basic injection technique remains similar, there may be slight differences in pen operation. Healthcare providers will offer guidance on using the new devices correctly.
What if I prefer my old pen?
Unfortunately, as the older models are discontinued, continuing with them is not a long-term option. The new pens offer comparable or improved functionality and are designed to enhance safety and ease of use.
Are the new pens covered by my insurance?
Coverage may vary depending on individual insurance plans. Patients should check with their insurance providers regarding coverage for SoloSTAR and ClikSTAR pens.
The Future of Insulin Delivery Devices
The discontinuation of OptiClik, OptiPen, and OptiSet pens and the focus on SoloSTAR and ClikSTAR devices reflect broader trends in diabetes care technology. Looking ahead, we can anticipate:
Integration with Digital Health Technologies
How might future insulin pens incorporate smart technology? We may see the development of insulin pens with built-in Bluetooth connectivity, allowing for seamless integration with smartphones and continuous glucose monitoring systems.
Enhanced Customization
What advancements in personalized insulin delivery can we expect? Future devices may offer more granular dose adjustments or incorporate algorithms to suggest dose modifications based on individual patient data.
Sustainability Initiatives
How will environmental concerns shape future insulin pen designs? There may be a greater emphasis on developing eco-friendly materials for pen construction or improving the recyclability of device components.
As diabetes care continues to evolve, the transition to SoloSTAR and ClikSTAR pens represents a step towards more standardized, user-friendly, and potentially safer insulin delivery methods. While the discontinuation of familiar devices may initially cause some concern among patients, the long-term benefits of this change are likely to contribute to improved diabetes management outcomes.
Healthcare providers, patients, and caregivers should view this transition as an opportunity to reassess and optimize insulin therapy regimens. By embracing these new tools and staying informed about best practices in diabetes care, the diabetes community can continue to work towards better glycemic control and improved quality of life for those living with the condition.
OptiClik, OptiPen and OptiSet insulin pens discontinued
- Skip to Content
- Skip to Main Navigation
- Skip to Information Links
- Skip to Site Search
- Skip to Footer
- Skip to Accessibility Information
- Home Page
This site is intended for UK healthcare professionals
Information Links
Mims
Main Navigation
-
Drugs -
Conditions -
News and resources -
MIMS Supported Resources
Search
Browse 3000+ drugs by disease
Browse drugs by 500+ manufacturers
Browse news and resources by disease area
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Browse all
3 January 2012
Following the publication of guidance by the National Patient Safety Agency on the reduction of insulin-related errors, Sanofi-aventis is reducing its range of insulin pens to two devices: pre-filled disposable SoloSTAR pens and the reusable ClikSTAR pen.
SoloSTAR and ClikSTAR will be the only insulin pen devices supplied by Sanofi-aventis for the treatment of diabetes
The following insulin devices have been discontinued: pre-filled disposable OptiSet, reusable OptiClik and reusable OptiPen Pro 1. In addition, Sanofi-aventis will no longer distribute the reusable Autopen 24. However, this pen will continue to be supplied by Owen Mumford and is compatible with ClikSTAR cartridges.
Patients using one of the discontinued pens can switch to using the available pens without the need to change their insulin as all the preparations will be available in the SoloSTAR and ClikSTAR range. Needles used with the older devices will continue to be compatible with the new pens.
Both the SoloSTAR and ClikSTAR allow users to select 1–80 units of insulin per dose, in 1 unit increments.
Further information: Sanofi-aventis
Want news like this straight to your inbox?
Sign up for our bulletins
- Diabetes
- Insulins
- News
- Licence changes & product updates
- Metered content
Have you registered with us yet?
Register now to enjoy more articles and free email bulletins
Register
Already registered?
Sign in
The most up-to-date drug information at your fingertips.
-
Get the prescribing support you need. -
Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?
Email address
Password
Stay signed in
Forgotten password?
Lantus SoloStar Insulin Pen | Lantus® (insulin glargine injection) 100 Units/mL
FEATURES OF LANTUS SOLOSTAR
ONCE-A-DAY
SMALL, THIN NEEDLES
“It’s such a small needle…it is very thin, so I hardly feel a thing. ” – JOSÉ, TREATING WITH LANTUS®️ SINCE 2007
Discomfort level associated with administration varies from person to person.
LARGE PRINT DOSING WINDOW
“The large window and big numbers are a real plus for me.” – JULIE, TAKING LANTUS® SOLOSTAR® SINCE 2009
Individual results may vary.
DIAL-IN DOSE
“When I use the pen, I know I’m getting the dose I dial every time.” – CLIFF, TAKING LANTUS SINCE 2010
PUSH-BUTTON INJECTION
“The features of the pen make it easier for me to use than a vial and syringe.” – AUDELLE, TAKING LANTUS SOLOSTAR SINCE 2007
To learn how to use the Lantus® SoloStar® pen, watch this video.
Interested in learning about how to use Lantus with a vial and syringe? Learn how.
Do NOT reuse needles. Needle not included with pen. Ultra-Fine is a trademark of Becton, Dickinson and Company.
JOSÉ MASTERS HIS DAILY ROUTINE*. WATCH NOW
*Users personal statements. Individual results may vary.
Discomfort level associated with administration varies from person to person.
Rotate your injection sites as instructed by your healthcare provider to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps). Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.
Important Safety Information | Full Prescribing Information
Download the Lantus SoloStar Injection Guide
GOT QUESTIONS?
See our FAQs. We’ll give you the answers to some of the most common questions asked about diabetes—and Lantus.
SEE OUR FAQS
SIGN UP FOR SAVINGS
If you are commercially insured, pay as low as $0 and no more than $99*. No insurance? We have an offer for you, too. Terms and restrictions apply*.
SIGNUP NOW
READY TO USE LANTUS?
Check out the “How to Use” video, learn about adjusting your dose, and more.
SEE HOW, NOW!
What is Lantus
® (insulin glargine injection) 100 Units/mL?
Prescription LANTUS is a long-acting man-made-insulin used to control high blood sugar in adults and children with diabetes mellitus.
- LANTUS is not for use to treat diabetic ketoacidosis
Which insulin is suitable for which insulin dispenser pen or pen injector how to find out
There are more and more names of insulins. In the materials of the article, some names of models of injection pens that have already been discontinued are used. I do this on purpose, because a person’s insulin changes, but the devices themselves remain. But this applies only to mechanical syringe pens or, as they are also called, dispensers and pen injectors. Penfill or disposable pen Penfill NovoNordisk, a manufacturer of such well-known insulins as NovoRapid, Actrapid NM, NovoMix 30, Protafan, Mixtard 30 NM and Levemir, produces penfills with a special plastic cap containing thread for winding a disposable needle. Very many times employees of Test-Poloska stores have encountered and continue to encounter situations when a diabetic first buys a syringe pen and only then goes to an endocrinologist to prescribe insulin. As a result, it turns out that the prescribed insulin is not suitable for this pen.
Flexpen Disposable Pen In essence, inside disposable flexpen are the most common penfills. Yes, yes, only in NovoNordisk flexpen are these ordinary penfills installed without plastic caps. Now focus. If suddenly the endocrinologist by mistake or due to the lack of penfills, for example, NovoRapida issued a flexpen with NovoRapid, then breaking it in half, you can pull the penfill out of the plastic shell and put on it the cap that I asked for (a little higher in the text ) do not throw away. Voila. Such a penfill can be safely inserted into the Novopen 3, Novopen 4 or Novopen Echo reusable syringe pen. In the same way, carefully and carefully breaking the QuickPen into two parts, you will receive an ampoule with Humalog, which can be inserted into the Humapen Ergo, Humapen Ergo II, Humapen Luxura without any cap. Needles for disposable and reusable pens
Mechanical or electronic Manufacturers came up with the idea that as soon as the built-in battery finishes working, the user will run to buy a new syringe pen. That is, someone will be able to earn all the time. Technically, even with a dead battery, you can dial a dose of insulin on an electronic syringe pen, but for this you will need to listen for clicks when typing. Personally, I am a supporter of classic mechanical syringe pens. Hocus Pocus Ear Trick A characteristic feature of the Humapen Luxura syringe pen is that the two halves of the pen are screwed together along a very strong and reliable thread. Penfill of the Apidra did not want to enter. Then we inserted the penfill into one part of the Humapen Luxura syringe pen, wound the needle and opened it, and then started screwing the two parts of the pen together. Excess insulin came out of the penfill, the piston moved and voila. So insulin “Apidra” found its life in a new pen, completely not intended for him. And there are many such tricks. Try.
1 “Lantus Opticlic Cartridge” is a penfill soldered into one replaceable part (half) of the handle. That is, half of the pen with electronic filling is a permanent part that is stored by the user. 2 Biomatic Pen is in fact a completely copied domestic analogue of the Optipen Pro 1 syringe pen. Releases the Pharmstandard device. All typographical errors in this article belong to Oleg Medvedev. |
|
Stary Oskol
Stary Oskol
Catalog
Catalog Product ov
Clothing and footwear
Clothing and footwear
Building materials
Building materials
Textiles and leather
Textiles and leather
Health and beauty
Health and beauty
Children’s goods
Children’s goods
Food and drink
Food and drink
Electrical engineering
Electrical engineering
Home and garden
Home and garden
Furniture and interior
Furniture and interior
Agriculture
Agriculture
Industry
Industry
All categories
Input Featured
Syringe – pen Opti Click (Opticlik) for Lantus insulin Type: syringe – pen , Type syringe : insulin,
DETAILS
Syringe – pen “NovoPen Echo” Type: syringe – pen , Manufacturer: Novo Nordisk, Type syringe : insulin
DETAILS
IME-FINE needle 31G x 6 mm to syringe – pen IME-FINE Type: needle, Needle type: for syringe – pens , Needle size:
IME-FINE needles 31G x 5 mm for syringe – pen IME-FINE Type: needle, Needle type: for syringe – pen , Needle size:
904 54 DETAILS
-24%
3680
4820
Syringe – pen HumaPen Ergo 2 Type: Injector, Size: Length 22. 000 Width 18.000 Height 5.000, Weight: 300
IN STORE
-28% 90 042
4 259
5900
Syringe – pen echomedmag, 3 ml, 1 pc. Type: Syringe – pen , Size: Length 20.000 Width 5.000 Height
IN STORE
-18%
1 366
1673 90 042
Syringe – pen Insulin syringes 0.5ml U-100 0.25x6mm 31G with needle, 0.5ml, 10 pcs. Type: Syringe – pen ,
IN STORE
-55%
1 364
3000
Syringe – pen ROSINSULIN ComfortPen Type: Syringe – pen , Size: Length 18.000 Width 5.000 Height 3.000,
IN STORE
-31%
881
1278
OneTouch Del lancing handle ica Plus Type: Lancing device, Size: Length 4.000
SHOP
-19%
1 050
1295
Syringe – pen bd insulin microfine+ 1ml n 10 (u100 g29 0.33×12.7) 3 pcs. Type: Syringe – Pen – pen Insulin, 1 ml, 200 pcs. Type: Syringe – pen , Size: Length 25.000 Width 20.000 Height
TO STORE
-19%
1 050
1295
Syringe – pen Insulin syringes 0.5 ml U-100 0 .25x6mm 31G with needle, 0.5ml, 10 pcs. Type: Syringe – pen ,
IN STORE
-26%
4 094
5500
Syringe – pen for HumaPen Luxura DT insulin in 0.5 unit increments. Type: Syringe – pen , Size: Length 19.000
SHOP
-18%
4 701
5700
Syringe – pen HumaPen Luxura DT Type: Injector, Size: Length 25.000 Width 13.0 00 Height 8.000, Weight:
IN STORE
Syringe – pen “NovoPen Echo” Type: Injector, Size: Length 22.000 Width 13.000 Height 5.000, Weight: 195
IN STORE
-18%
1 842
2250
Syringe – pen ROSINSULIN ComfortPen Type : Injector, Size: Length 25.000 Width 11. 000 Height 8.000,
SHOP
-19%
1 667
2051
Syringe – pen Insulin syringes 9 0045 0.5ml U-100 0.25x6mm 31G with needle, 0.5ml, 10 pcs. Type: Syringe – pen ,
IN STORE
-31%
2 427
3500
Syringe – pen Rinsa Pen 2 for insulin delivery step 1 unit Type: Syringe – pen , Size: Length 25.000
SHOP
-40%
2 712
4500
Syringe – pen RinsaPen 2, 3 ml, Type : Endoscopy equipment, Size: Length 10.000 Width 5.000
V STORE
Syringe – pen NovoPen Echo pitch 0.5 Type: syringe – pen , Manufacturer: Novo Nordisk, Type syringe :
DETAILS
9004 4 Syringe – pen NovoPen Echo1 pc. Type: syringe – pen , Manufacturer: Novo Nordisk, Type syringe : insulin
DETAILS
Syringe – pen NovoPen Echo/NovoPen Echo (red), step 0.